scholarly article | Q13442814 |
P356 | DOI | 10.2174/0929867323666161227094049 |
P698 | PubMed publication ID | 28025938 |
P50 | author | Ivan Beltran-Hortelano | Q89347728 |
P2093 | author name string | Silvia Galiano | |
Silvia Perez-Silanes | |||
P2860 | cites work | Development of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitors | Q33419478 |
P433 | issue | 11 | |
P921 | main subject | Trypanosoma cruzi | Q150162 |
Chagas disease | Q649558 | ||
P304 | page(s) | 1066-1138 | |
P577 | publication date | 2017-05-01 | |
P1433 | published in | Current Medicinal Chemistry | Q3007710 |
P1476 | title | Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease | |
P478 | volume | 24 |
Q92774155 | Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity |
Q61798291 | Oxidative Stress in Microbial Diseases: Pathogen, Host, and Therapeutics |
Q98508491 | Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism |
Q58865487 | Relevance of Trypanothione Reductase Inhibitors on Trypanosoma cruzi Infection: A Systematic Review, Meta-Analysis, and In Silico Integrated Approach |
Search more.